Published in Hepatitis Weekly, October 23rd, 2006
Study 1: Recent research from the United States has reported on the inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike (S) protein.
"SARS-CoV is the cause of an atypical pneumonia that affected Asia, North America and Europe in 2002-2003. The viral S glycoprotein is responsible for mediating receptor binding and membrane fusion," wrote B. Sainz and colleagues, Scripps Research Institute.
They continued, "Recent studies have proposed that the carboxyl terminal portion (S2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.